Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Hikma Pharmaceuticals    HIK   GB00B0LCW083

Delayed Quote. Delayed  - 08/16 05:35:09 pm
1329 GBp   +0.76%
08/16 HIKMA PHARMACEU : - Notice of results
08/09 HIKMA PHARMACEU : Director/PDMR Shareholding
06/01 FTSE flirts with record level though sterling boost fades; Inmars..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Analysis summary4-Traders Strategies

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/01/1970 CEST
 :

© Zonebourse.com
share with twitter share with LinkedIn share with facebook
share via e-mail
0

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Company
Develops, manufactures and markets branded and non-branded generic and in-licensed productsHikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products.It operates through the following segments: Branded, Injectables,... 
Sector
Pharmaceuticals
Calendar
08/17Earnings Release
Financials ($)
Sales 2017 2 067 M
EBIT 2017 406 M
Net income 2017 219 M
Debt 2017 479 M
Yield 2017 1,79%
P/E ratio 2017 18,65
P/E ratio 2018 13,63
EV / Sales 2017 2,22x
EV / Sales 2018 1,99x
Capitalization 4 115 M
Chart HIKMA PHARMACEUTICALS
Duration : Period : Day
Hikma Pharmaceuticals Technical Analysis Chart | HIK | GB00B0LCW083 | 4-Traders
Duration : Period : Week
Hikma Pharmaceuticals Technical Analysis Chart | HIK | GB00B0LCW083 | 4-Traders
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes